Meghmani Organics Ltd
Meghmani Organics Ltd
ChemicalsKey Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Meghmani Organics Ltd insights
49 extracted metrics + investor summaries across FY20–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Stock is trading at 0.99 times its book value
- Company's working capital requirements have reduced from 19.6 days to 10.4 days
Weaknesses
3- The company has delivered a poor sales growth of 5.84% over past five years.
- Company has a low return on equity of -1.94% over last 3 years.
- Earnings include an other income of Rs.91.8 Cr.
Growth Rate
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 426 | 379 | 352 | 410 | 414 | 544 | 569 | 553 | 614 | 577 | 509 | 474 | 543 |
| Expenses | 448 | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 | 471 | 455 | 445 |
| Operating Profit | -22 | 8 | -8 | 2 | 6 | 31 | 41 | 65 | 67 | 52 | 38 | 20 | 98 |
| OPM % | -5% | 2% | -2.2% | 0.5% | 1.4% | 6% | 7% | 12% | 11% | 9% | 7% | 4.2% | 18% |
| Other Income | 7 | 12 | 10 | 9 | 9 | 12 | 9 | 14 | 17 | 28 | 15 | 37 | 12 |
| Interest | 4 | 13 | 27 | 2 | 11 | 26 | 13 | 19 | 29 | 24 | 18 | 20 | 13 |
| Depreciation | 24 | 23 | 23 | 23 | 23 | 25 | 30 | 29 | 30 | 30 | 30 | 29 | 30 |
| PBT | -43 | -16 | -48 | -14 | -19 | -9 | 7 | 31 | 24 | 26 | 4 | 7 | 67 |
| Tax % | -20% | -3% | -20% | 25% | -13% | 1% | 159% | 35% | 48% | 56% | 179% | -12% | 28% |
| Net Profit | -34 | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 | 8 | 48 |
| EPS in Rs | -1.36 | -0.6 | -1.5 | -0.71 | -0.66 | -0.36 | -0.17 | 0.78 | 0.5 | 0.45 | -0.14 | 0.32 | 1.89 |
Profit & Loss
| Mar 2020 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 700 | 1,637 | 2,498 | 2,553 | 1,566 | 2,080 | 2,174 | 2,103 |
| Expenses | 595 | 1,353 | 2,119 | 2,211 | 1,586 | 1,936 | 1,996 | 1,896 |
| Operating Profit | 105 | 283 | 379 | 342 | -19 | 144 | 178 | 207 |
| OPM % | 15% | 17% | 15% | 13% | -1.2% | 7% | 8% | 10% |
| Other Income | 130 | 30 | 102 | 114 | 37 | 42 | 95 | 92 |
| Interest | 18 | 11 | 9 | 66 | 46 | 69 | 92 | 75 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 | 119 |
| PBT | 194 | 252 | 409 | 313 | -121 | 9 | 62 | 105 |
| Tax % | 23% | 26% | 26% | 24% | -12% | 212% | 54% | — |
| Net Profit | 150 | 186 | 304 | 238 | -106 | -11 | 29 | 64 |
| EPS in Rs | 29,914 | 37,296 | 11.97 | 9.35 | -4.17 | -0.42 | 1.13 | 2.52 |
| Div. Payout % | 17% | 19% | 12% | 15% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 961 | 1,148 | 1,441 | 1,644 | 1,502 | 1,490 | 1,519 |
| Borrowings | 264 | 268 | 499 | 824 | 837 | 829 | 726 |
| Other Liabilities | 407 | 533 | 832 | 705 | 676 | 741 | 750 |
| Total Liabilities | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 | 3,085 | 3,021 |
| Fixed Assets | 481 | 634 | 911 | 1,166 | 1,152 | 1,575 | 1,494 |
| CWIP | 101 | 112 | 188 | 356 | 521 | 83 | 87 |
| Investments | 191 | 304 | 211 | 183 | 114 | 3 | 5 |
| Other Assets | 885 | 924 | 1,487 | 1,494 | 1,253 | 1,425 | 1,435 |
| Total Assets | 1,657 | 1,974 | 2,798 | 3,198 | 3,040 | 3,085 | 3,021 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | 22 | 333 | 65 | 204 | 250 | 66 | 222 |
| Investing | 13 | -307 | -133 | -418 | -178 | 31 | -38 |
| Financing | -26 | -14 | 58 | 234 | -85 | -91 | -190 |
| Net Cash Flow | 8 | 12 | -10 | 21 | -14 | 6 | -7 |
| Free Cash Flow | -49 | 124 | -177 | -259 | -14 | -20 | 178 |
| CFO/OP | 48 | 143 | 42 | 84 | -1,328 | 49 | 141 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 241 | 92 | 79 | 75 | 101 | 99 | 113 |
| Inventory Days | 271 | 152 | 161 | 158 | 185 | 173 | 145 |
| Days Payable | 209 | 137 | 144 | 108 | 176 | 159 | 149 |
| Cash Conversion Cycle | 302 | 106 | 96 | 124 | 109 | 113 | 110 |
| Working Capital Days | 152 | 57 | 57 | 53 | 28 | 20 | 10 |
| ROCE % | — | 19% | 24% | 16% | -3% | 3% | 7% |
Documents
Frequently Asked Questions about Meghmani Organics Ltd
What does Meghmani Organics Ltd do?
Where is Meghmani Organics Ltd (MOL) listed?
Which sector does Meghmani Organics Ltd belong to?
What is the market capitalisation of Meghmani Organics Ltd?
What is the PE ratio of Meghmani Organics Ltd?
What is the 52-week high and low of Meghmani Organics Ltd?
Does Meghmani Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Meghmani Organics Ltd?
How can I research Meghmani Organics Ltd on Tapetide?
Company Information
Founded in 1986 as M/s Gujarat Industries, the company was incorporated in 1995 as Meghmani Organics Limited. The company manufactures Pigments and Agrochemicals through its 6 manufacturing facilities located in Gujarat. The company is amongst the top 3 Phthalocyanine based pigment players in the world and amongst the top 10 producers of pesticides in India.[1]Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber. It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage.